Mirum Pharmaceuticals, Inc. (MIRM) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2018: -$17.31M2019: $130.35M2020: $172.09M2021: $120.21M2022: $142.04M2023: $248.67M2024: $225.64M2025: $314.69M$314.69M
2018Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$314.69M+39.5%
2024$225.64M-9.3%
2023$248.67M+75.1%
2022$142.04M+18.2%
2021$120.21M-30.1%
2020$172.09M+32.0%
2019$130.35M+852.9%
2018-$17.31M